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The rapid increase of drug resistant bacterial makes necessary the development of new 
antimicrobial agents. Synthetic amino acid-based surfactants constitute a promising 
alternative to conventional antimicrobial compounds given that they can be prepared 
from renewable raw materials. In this review, we discuss the structural features that 
promote antimicrobial activity of amino acid-based surfactants. Monocatenary, 
dicatenary and gemini surfactants that contain different amino acids on the polar head 
and show activity against bacteria are revised. The synthesis and basic physico-chemical 
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The rapid increase of multiple drug resistant bacteria and fungi poses a serious threat to 
society [1]. For example, in the United States and the United Kingdom, 40-60% of 
nosocomial Staphylococcus aureus strains are methicillin-resistant (MRSA) [2] and 
more deaths are associated with MRSA than with methicillin-sensitive strains [3]. 
Therefore, there is an urgent necessity to design new antimicrobial compounds that 
impede the development of acquired resistance.  One possible strategy is the preparation 
of compounds with novel modes of action and different targets compared to existing 
antibiotics. 
Cationic antimicrobial peptides (AMPs) are emerging as potent antimicrobial agents. 
Produced by all types of living organisms, AMPs are key components of the innate 
immune system and are active against invading pathogens, including bacteria, fungi and 
yeast [4]. These antimicrobials consist of 12-50 amino acids that show a net positive 
charge at physiological pH and a hydrophobic bulk. An optimal association between the 
cationic charge and the hydrophobic part of the molecule was found to be crucial for the 
antimicrobial activity of these compounds [5]. Importantly, AMPs usually work through 
relatively non-specific modes of action, in contrast with conventional antibiotics, which 
target specific enzymes or DNA. Instead of targeting a single molecule or process, they 
associate with cellular membranes, resulting in depolarization, lysis, and cell death, 
probably due to their successful incorporation into the hydrophobic lipid bilayer [6]. 
This hampers the development of bacterial resistance against their activity. However, in 
spite of the excellent antimicrobial performance of AMPs, there are some drawbacks in 
their application [7]: a) their chemical synthesis entails a high production cost, b) linear 
peptides are often easily proteolytically degraded, and c) they are not generally cell-
specific and are also toxic to mammalian cells. 
Native lipopeptides composed of an aliphatic acid attached to a short peptide portion of 
six or seven amino acids are also effective antimicrobial agents. Like AMPS, they act 
via perturbation of the bacterial membrane [8], and have the same disadvantage in that 
they are toxic to mammalian cells due to a lack of selectivity [9].  
Classic cationic surfactants derived from quaternary ammonium groups are also applied 
for their antimicrobial properties [10]. In fact, these surfactants have been used for well 
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over half a century as antiseptics together with products such as dressing, catheters and 
sutures. By reducing hospital infections, cationic antimicrobials diminish the need for 
antibiotics, which has had a positive impact on antibiotic resistance development. 
Moreover, despite their widespread usage, no apparent reduction in their effectiveness 
has been observed.  Nevertheless, they are not suitable for biomedical applications due 
to their haemolytic activity and cytotoxicity [11]. Their use is also seriously questioned 
from an environmental point of view as they are not readily biodegradable and are toxic 
to aquatic organisms [12]. Insufficient biodegradation of chemical compounds increases 
their toxicity, given that aquatic organisms have more time in contact with them. 
Laboratory studies have shown that dimethyldidecyl ammonium chloride is 
hydrolytically stable and resistant to microbial degradation and the predicted half-lives 
in aquatic environments are equal to or longer than 3 years [13]. 
 
Nowadays, synthetic cationic amino acid-based surfactants are being explored as 
promising alternatives to conventional antimicrobial agents. Structurally, these 
compounds can be considered as analogues of native lipopeptides since they are cationic 
amphiphiles consisting of one or two amino acids linked to a hydrophobic moiety. They 
therefore share the same mode of action against microorganisms and low susceptibility 
to inducing resistance.  
The interaction of cationic amphiphiles with microorganisms involves two main steps. 
Firstly, the amphiphile becomes attached to the target membrane, a process governed by 
electrostatic interactions between the positively charged polar head of the surfactants 
and the negatively charged molecules of the bacterial membranes (lipopolysaccharides 
in Gram-negative and lipoteichoic acid in Gram-positive bacteria) [14]. These 
electrostatic interactions are also entropically favored due to the release of counterions. 
Subsequently, the hydrophobic alkyl chain of cationic amphiphiles interacts with the 
lipid bilayers of membranes, modifying the membrane architecture and promoting the 
transport of intracellular constituents across the cell membranes [15]. In this second 
step, an optimum relationship between the hydrophobicity and polarity of the surfactant 
is necessary to facilitate the diffusion of the surfactant in the non-polar environment of 
lipid bilayers. This mechanism explains the activity of cationic surfactants, generally 
more potent against Gram-positive bacteria, which contain high amounts of negatively 
charged lipids. Most of them do not show antifungal activity because the negative 
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charge density at the cell membrane in these microorganisms is lower than in bacteria 
[16]. 
The high number of different types of amino acids, as well as their diverse nature (polar, 
non polar, acidic, basic), allows a wide range of cationic amphiphile structures with 
diversified specifications to be designed. Furthermore, given their simple structure, 
consisting of one or two amino acids linked to an aliphatic chain, their synthesis does 
not involve many steps. Consequently, their manufacturing cost is economically viable 
and they can be prepared in accordance with the current environmental regulations (use 
of renewable starting materials with a low volume of hazardous solvents). In general, 
these kinds of surfactants can be considered as readily biodegradable compounds. One 
of the major advantages of antimicrobial amino-acid surfactants is their double 
functionality: as well as featuring the typical properties of surface active molecules 
(forming molecular aggregates as micelles or vesicles and thereby reducing surface 
tension), they can also act as antimicrobial agents.    
 
2. Structure, synthesis and properties of antimicrobial amino acid-based surfactants 
 
2.1.  Single chain surfactants with one amino acid  
Amino acid-based surfactants constitute an interesting alternative to conventional 
synthetic surfactants, bearing some of the fundamental requirements for industrial 
development: (a) multifunctionality, (b) low toxicity, (c) renewable sources of raw 
materials, (d) biodegradability and (e) simple synthesis. 
Amino acids have at least two functional groups, the carboxylic group and the amino 
group. These compounds can be easily converted to single chain surfactants with a 
reactive molecule bearing a hydrophobic chain, such as fatty acids, fatty esters, fatty 
amines and fatty alcohols. The hydrophobic chain can be introduced into the amino acid 
structure through ester alkyl or amide linkages (Figure 1). 
Amino acids with reactive side chains such as lysine or arginine offer additional 
opportunities for the molecular design of monocatenary surfactants. From an 
economical and environmental point of view, single chain surfactants with only one 







Due to the presence of a guanidine group, the arginine amino acid is an excellent raw 
material to prepare surfactants with antimicrobial activity. The literature describes a 
significant number of compounds with excellent antiseptic and pharmacological 
behaviour whose common feature is strongly basic groups of the guanidine type 
attached to a fairly large lipophilic molecule [17]. Our group has developed different 
synthetic routes (chemical, enzymatic or a combination of both methodologies) to 
prepare a wide range of single chain arginine structures (Figure 2) [18]. 
 
Long chain Nα-acyl arginine methyl or ethyl ester surfactants (Figure 2, series 1) were 
synthesized by the condensation of one hydrophobic group to the α-amino group of the 
arginine methyl or ethyl ester. The guanidine side chain of arginine is an extremely 
strong base, which in an unsubstituted state remains protonated under normal conditions 
for α-acylation [19]. It is therefore possible to work with an unprotected arginine side 
chain by carefully controlling the pH, and dicyclohexyl carbodiimide can be used to 
condense the fatty acid [20]. This method allowed the use of very mild experimental 
conditions, thereby avoiding racemization and the formation of undesirable by-products. 
The long fatty acyl chain can also be introduced with the corresponding acid chloride by 
using a mixture of water/acetone as the solvent or only water [21]. 
Arginine-n-alkyl amide dihydrochlorides (Figure 2, series 2) and arginine-O-alkyl ester 
dihydrochlorides (Figure 2, series 3) contain two positively charged groups in the polar 
head, one in the primary amine and the second in the guanidine function. Series 2 was 
first prepared by chemical procedures involving the condensation of the carboxylic 
group of Boc-protected arginine with the corresponding long chain alkylamine [22]. 
After that, an enzymatic procedure that allowed the preparation of series 2 and 3 was 
described [23]. Papain (from Carica Papaya) deposited onto polyamide was found to be 
the best biocatalyst configuration for the formation of amide (series 2) and ester (series 
3) bonds between Cbz-arginine methyl ester and various long chain amines and fatty 
alcohols. The sodium salts of Nα-acyl arginine (Figure 2, series 4) are amphoteric 
surfactants that contain one positive charge (guanidine group) and one negative charge 
(carboxylic group) on the polar head. The net charge of these surfactants depends on the 
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pH of the medium. These compounds were prepared by chemical hydrolysis of the 
corresponding Nα-acyl arginine methyl esters [24].  
Surfactants of series 5 (Figure 2) have a hydrophobic chain attached to the glycerol 
backbone through ester bonds and a polar head from the arginine with two positive 
cationic charges. Structurally, they can be regarded as analogues of the monoglycerides. 
Their preparation involved a three-step procedure, beginning with the formation of an 
ester linkage between the carboxylic acid of the protected arginine and the terminal OH 
group of the glycerol. The other terminal free hydroxyl group of the intermediate was 
then acylated with the corresponding long chain acid chloride, and finally, the protected 
group of the arginine was removed by catalytic hydrogenation [25]. 
Some of the basic physicochemical properties [critical micellar concentration (cmc), 
surface tension at the cmc (γcmc) and minimum area per molecule (Amin)] were obtained 
from the surface/concentration curves at 25ºC (Table 1). The cationic single chain 
arginine-based surfactants presented good aqueous solubility, whereas amphoteric 
surfactants (series 4) were only sparingly soluble in water, making it impossible to 
determine the cmc. [24]. 
The cmc of these surfactants is mainly governed by the alkyl chain length. In all the 
cationic series, the more methylene groups in the hydrophobic moiety, the lower the 
cmc, as would be expected from the increasingly hydrophobic character of the molecule 
[26].  Surfactants from series 5 (arginine monoglycerides) showed slightly lower cmc 
than those from series 1, 2 and 3 [27]. The presence of the glycerol backbone increases 
the distance between the ionic group and the α-carbon atom of the hydrophobic group, 
resulting in a lower cmc. The area per molecule of surfactants with two positive charges 
on the polar head was larger than that of surfactants with only one cationic charge 
(series 1).  The two positively charged groups in series 2 and 3 tended to spread 










Antimicrobial properties of single chain arginine-derived surfactants 
The antimicrobial activity of these derivatives, based on the minimum inhibitory 
concentration (MIC μg/mL), is presented in Table 2. In the case of these single chain 
arginine-based surfactants, the MIC occurred below the corresponding cmc, suggesting 
that the species interfering with the cellular surface are monomers, not aggregates [26]. 
As shown in Table 2, these compounds have a wide spectrum of action and exhibited 
good inhibitory behavior including Gram-negative bacteria. The antimicrobial 
efficiency of these surfactants was affected by the alkyl chain length, the maximum 
activity of surfactants of series 1 was obtained for alkyl chain of 12 carbon atoms 
(Table 2). The methyl ester or ethyl ester group in the analogues LAM and LAE did not 
affect the antimicrobial activity, both compounds showing a similar range of MIC 
values. 
The antimicrobial activity of cationic surfactants in general depends on the length of the 
alkyl chain, although the correlation is not clear. Other parameters, such as aqueous 
solubility, cmc, hydrophobicity and adhesion, also determine the interaction of 
surfactant molecules with the cellular envelope. Alkyl chains bearing 12 and 14 carbon 
atoms often show the highest biocidal function. For example, in alkylguanidine-based 
surfactants, the highest activity also corresponded to the dodecyl derivative. A study of 
the interaction of these alkylguanidine-based surfactants with bovine serum albumin 
(BSA) indicated that longer chains enhance the effects on the BSA conformation [28]. 
Bera et al found in a series of guanidinylated neomycin- and kanamycin-derived 
surfactants that the number of cationic charges as well as the nature and size of the 
polycationic head groups affected antibacterial performance, the most active alkyl 
chains having 11 and 15 carbons. Interestingly, the optimal activity against Gram-
positive bacteria was achieved by the conjugation of a polyamine head group to 
saturated C16 or C20 alkyl chains, whereas for the neomycin B-derived polyguanydilated 
head groups, induction of anti Gram-positive activity was obtained with shorter lipid 





Arg-N-alquyl amide surfactants (series 2) are also very effective agents against Gram-
positive and Gram-negative bacteria [26]. The tolerance of Gram-negative bacteria to 
biocides is well known, their outer membrane obstructing biocide entry, due to the 
intrinsic permeability barrier and the role of lipopolysaccharides, which is not yet 
understood [30]. Nevertheless, series 1 and 2 analogues exhibited similar levels of 
activity against both types of bacteria. In series 2 the maximum activity was obtained 
for ALA with MIC values similar to those obtained for LAM and LAE (series 1). In 
Series 2 the variation of MIC with the alkyl chain length was less pronounced. An 
important structural difference between series 1 and 2 was the number of positive 
charges per molecule. The presence of two cationic charges in series 2 did not affect the 
performance of the most active compound, enhancing it in the case of n=10 and n=14. 
By changing the chemical bond that links the hydrophobic group with the polar head 
from amide to ester (series 3), the activity decreased drastically. The ester bond might 
be easily hydrolyzed by bacteria, which would eradicate the antimicrobial activity of the 
compounds.    
The standard monoglycerides (decylglycerol and dodecylglycerol) have no or negligible 
antimicrobial properties; the introduction of arginine (series 5), which contains a 
guanidinyl group, confers moderate activity, with no relevant differences between 
Gram-positive and Gram-negative bacteria [25].  
The antimicrobial effect of all these series seems to be linked to the presence of cationic 
charges, since the sodium salt of Nα-acyl arginine hydrochloride (series 4) did not have 
antimicrobial activity [24]. In homologues of series 4, the positive charge of the 
guanidyl group is neutralized by the negative charge of the carboxylic group, giving rise 
to molecules without any net cationic charge.  
Although the mechanisms of action of biocides are still far from elucidation, biocide 
surfactants are known to act predominantly on cellular envelopes. Flow cytometry 
experiments demonstrated that, after 30 min of treatment at the corresponding MIC, the 
LAE (series 1) cause depolarization and disruption of the cellular membrane, which 
leads to the collapse of the respiratory chain and blockage of the proton motive force 
(90.7% of S. Typhimurium and 56.3% of S. aureus) [31]. Due to this microbial damage, 
cell viability is reduced by 98.8%. Ultrastructural changes were also observed by 
transmission electron microscopy (TEM). This technique detected lesions on the  
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cellular envelopes as well as intracellular changes in the appearance of the cytosol in the 
Gram-negative S. Typhimurium. In the Gram-positive S. aureus, the microphotographs 
revealed invaginations of the membrane (mesosomes), abnormal septation and irregular 
cross-wall formations.   
Biological properties of single chain arginine-derived surfactants 
Biological properties of single chain arginine surfactants such as haemolysis, ocular 
irritation, aquatic toxicity and biodegradability have also been reported. The ability of 
surfactants to disrupt membrane integrity by a hydrophobic/ionic adsorption 
phenomenon at the cell membrane /water interface is related with their toxicity. Nα-acyl 
arginine derivatives (series 1) showed moderate haemolytic activity with HC50 values of 
38-59 μg/mL [32]. Their ecotoxicity was evaluated using two aquatic species: Daphnia 
magna and Photobacterium phosphoreum bacteria. It was found that: (1) the acute 
toxicity of arginine-derived cationic surfactants was clearly lower than that reported for 
conventional monoquats, (2) salt water bacterial cells are more sensitive than Daphnia 
to arginine-derived surfactants, (3) compounds of series 1 and 2 are more toxic than 
those of series 3 and 5 and (4) acute toxicity grew with increasing hydrophobicity in 
each series of surfactants, in agreement with cmc values [26,27]. Biodegradation studies 
indicated that all compounds except AMA can be regarded as readily biodegradable. 
The rate of biodegradability depends on the alkyl chain length and is accelerated by the 
incorporation of ester functionality. It can therefore be concluded from available data 
that hydrophobicity is a negative parameter for the toxicity and biodegradability of 
arginine-derived surfactants.  
2.1.2. Lysine  
Lysine is an essential basic amino acid that contains one carboxylate and two amino 
groups. The presence of these three reactive sites allows the synthesis of cationic 
surfactants with a polar head of variable ionic character by the introduction of 
hydrophobic groups in the molecule (Figure 3). Amphiphiles with different structures 
can be designed by hydrophobic modulation, although most of the antimicrobial single 
chain surfactants from lysine are Nα- or Nε-acyl lysine derivatives. These N-acyl lysine 
compounds have the cationic charge on one of the protonated amino groups of lysine, 
and they present an acid-base equilibrium in aqueous solutions. Given that their cationic 
character depends on the pH of the medium, these amphiphiles behave as pH-sensitive 
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surfactants. Notably, the pKa of the two lysine amino groups differs considerably, the 
pKa of the α-amino group is 8.9 while the pKa of the ε-amino group is 10.5. At a pH 
equal to the pKa, the amino acid will be 50% protonated, giving an average charge of 
0.5. When the pH decreases by more than 2 units from the pH=pKa value, it can be 
considered that the amino acid is 100% protonated and the average charge is 1. Given 
this substantial difference in the pKa of the two amino groups of the N-acyl lysine 
derivatives, the ionic character depends on the position of the cationic charge (α-amino 
or ε-amino group). 
Our group prepared cationic Nε-acyl lysine methyl ester (Figure 3, series 6) and Nα-acyl 
lysine methyl ester (Figure 3, series 7) to study the influence of the position of the 
cationic charge on the biological properties of these compounds. The surfactants were 
synthesized by lysine acylation at the ε or α position of the protected Nα or Nε-
carbobenzoxi-lysine methyl ester and the protecting group was subsequently removed 
by catalytic hydrogenation [33]. Cationic surfactant NεNεNε-trimethyl-Nα-lauroyl lysine 
derivatives (Figure 3, series 8) were prepared from the corresponding ester of Nα-
lauroyl lysine by the quaternization of the ε-amino group using methyl iodine. The cmc 
of these surfactants is similar, between 2 and 4 mM, respectively [34]. Moreover the 
NαNαNα-trimethyl-Nα-miristoyl lysine methyl (MKM)q ester was also prepared using the 
same methodology (Figure 3, series 9).  
Lysine-based surfactants in which the hydrophobic part is linked to the carboxylic 
lysine group through an ester or amide bond have also been described. Nakamiya et al. 
prepared amino acids lauroyl ester (Figure 3, series 10) and lysine lauroyl amides 
(Figure 3, series 11), which can contain in the molecule 1 or 2 positive charges [35]. 
Using classical reactions in peptide chemistry, Mondal el al. synthesized a lauroyl 
amide of lysine (Figure 4, 12), guanidinylated lauroyl amide of lysine (Figure 4, 13) and 
polyol-modified carbohydrate-templated lauroyl amide of lysine (Figure 4, 14). These 
authors studied how these structural modifications affected the antimicrobial properties 
of these compounds [36].  
TABLE 3 
 
The pKa values of the N-acyl lysine methyl ester derivatives indicated that their cationic 
character depends on the pH of the medium (Table 3). This behavior is common in 
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amino acid-based surfactants, as well as in other cationic surfactants in which the 
cationic charge is on a protonated amine group [37]. The introduction of hydrophobic 
groups in the amino acid drastically reduces the apparent pKa, the decrease being more 
pronounced the longer the hydrophobic group [38]. For the same alkyl chain length, the 
pKa values of Nα-acyl lysine derivatives were higher than those of the Nε-acyl- lysine 
methyl ester, whereas the cmc were in the same order.  
 
Antimicrobial properties of lysine-based surfactants 
MIC values of the Nα-lauroyl-Lysine methyl and ethyl ester hydrochloride analogues 
(series 7) are summarized in Table 4. This family of lysine surfactants exhibited a wide 
spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria, 
with MIC values in the same order as those of arginine analogues [34]. The 
stereochemistry of these Nα-lauroyl-Lysine surfactants did not influence their 
antimicrobial properties, which did not differ significantly between DL-LLM and L-
LLM. The fact that these surfactants maintained their activity independently of their 
optical purity is of great interest, given the high cost of isolating pure diasterioisomers 
[39]. The ethyl derivative analogue (series 7, LLE) showed higher activity than the 
methyl analogue (series 7, LLM). No changes were observed when three methyl groups 
were introduced into the amino group of these molecules (series 8, LLMq and LLEq). 
The comparable antimicrobial activity of the trimethylated and non-trimethylated 
derivatives could be ascribed to their similar cationic charge density. The pKa of the Nα-
acyl-lysine surfactants was around 9 (Table 3); in the medium used to determine the 
MIC, all molecules were protonated and the net cationic charge can be considered as 1 
per molecule [40]. As the trimethylated analogues have a fixed positive charge 
independently of the pH, the net positive charge was also 1.  
After the alkyl chain was moved from the α-amino to the ε-amino group of lysine, the 
antimicrobial properties decreased considerably (series 6), and none of the homologues 
showed activity against Gram-negative bacteria [33,40]. Usually antimicrobial 
surfactants have less impact on Gram-negative bacteria, since the lipopolysaccharide-
packed outer envelopes prevent the entrance of amphiphilic compounds. The MIC 
values obtained for all these lysine derivatives confirmed that the cationic charge 
density of surfactants strongly affects their biocide character. Indeed, the LLS surfactant 
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(series 7), amphoteric without any charge, was not active against any of the bacteria 
tested [34]. Taking into account the pKa values of series 6, it can be assumed that the 
cationic charge density of these surfactants is lower than that of LLM or LLE (series 7). 
Moreover, it was observed that, by fixing the cationic charge in the Nε-Miristoyl-lauroyl 
methyl ester (series 9, MKMq), the activity improved considerably [40]. Then, for 
amino acid-based cationic surfactants in which the cationic charge lies on a protonated 
amine group, the antimicrobial activity depends on the pKa of the latter. Compounds 
with pKa values higher than 9 exhibit good activity, while those with a pKa lower than 
7 are less potent, especially against Gram-negative microorganisms.  
Nakamika reported the activity of compounds consisting of one amino acid, with one 
alkyl chain linked to the carboxylic group of the amino acid through an ester bond 
(series 10). Compounds prepared with basic amino acids (lysine and arginine) 
containing two positive charges showed good antimicrobial activity against the three 
microorganisms tested (E. coli, S. aureus, P. aeruginosa). However, the surfactants 
prepared with neutral amino acids (valine, proline, pheylalanine etc.), bearing a single 
positive charge on the α-amino group of the amino acid, only affected one of the 
bacteria tested [35]. The pKa of the α-amino group of amino acids linked to alkyl chains 
is about 6-7, which means that solutions prepared with these compounds at pH=7 
contain a high percentage of non-protonated molecules and consequently the surfactant 
antimicrobial activity is low. These authors did not observe any variation in biocide 
activity after substituting the ester bond by an amide bond (series 11), in contrast with 
the results obtained by Moran el al. for similar arginine derivatives [26].  
The MIC values obtained by Mondal et al. for compound 12 agree with those published 
previously for similar derivatives with different counterions [36]. This surfactant also 
showed good activity against Methicillin-resistant S. aureus and Methicillin-resistant S. 
epidermidis (MIC values of 4 and 8 μg/mL, respectively). The guanidinylation of the 
two amino groups of lysine in compound 12 (compound 13) enhanced antibacterial 
performance. However, the substitution of lysine in cationic lipid 12 by a gluco-
templated lysine (compound 14) enhanced the hydrophobicity of the polar group and 
reduced antibacterial activity.  
It is known that biocides have multiple targets. The first interaction of surfactants 
occurs at the solid/liquid interphase on the envelope of the microbial cell. They then 
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interact with the cytoplasmic membrane at different levels, disrupting the cellular 
membrane and damaging the proton motive force and enzyme transport or enzyme-
associated membrane activity. Once the biocide enters the cytoplasm, variable damage 
might be expected, depending on the compound or the nature of the bacterial cell. 
Transmission electron microscopy (TEM) revealed that S. aureus cells treated with 
LLM (series 7) at MIC (63 μg/mL) had vesicles in the peripheral region of the 
cytoplasm, as well as bubbles protruding from the cell mesosomes (Figure 5, a, b) [41].  
When an E. coli population was treated with LLM (series 7) at MIC (125 μg/mL) (Fig 
5c,d), it was observed collapse of part of the cytoplasm as well as numerous vesicles in 
the extracellular space. However, no disruption of the inner membrane was observed.  
The main parameters that affected the haemolytic activity of monocatenary lysine 
surfactants were the same that governed their antimicrobial activity: the alkyl chain 
length and cationic charge density. Compounds from series 6 showed low pKa values 
and consequently their cationic charge density at neutral pH was also low. These 
surfactants showed little haemolytic activity (HC50 values > 200 μg/mL) and the 
disruption of red blood cells decreased as the alkyl chain lengthened [33]. For the same 
12-carbon alkyl chain, the haemolytic activity increased by increasing the charge 
density; the HC50 of LKM (series 6) was 391 μg/mL, while HC50 of LLM (series 7) was 
199 μg/mL [40]. 
2.1.3. Other amino acids 
 
Low molecular-weight gelators have generated significant interest in biomedicine. 
Cationic surfactants based on L-tryptophan (Figure 6, series 15) and L-tyrosine (Figure 
6, compounds 16) have proved to be excellent gelators and exhibit remarkable 
bactericidal properties. Surfactants from series 15 were prepared by coupling Boc-
protected L-tryptophan with hexadecylamine using dicyclohexylcarbodiimide (DCC), 
and the Boc protector group was subsequently removed by trifluoroacetic acid (TFA) 
[42]. The chloride counterion of these tryptophan-based surfactants was changed to 
various organic carboxylates in order to investigate counterion-induced variation in 
antimicrobial activity and cytotoxicity  [43]. 
 
For n=15, the critical concentration at which the surfactant of series 15 and the 
compound 16 (Figure 6) began to self-assemble (cmc) was 0.13 and 0.08, respectively. 
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These cationic surfactants developed spontaneous vesicles by mixing at room 
temperature transparent aqueous solutions of these cationic surfactants and anionic 
surfactants like sodium dodecyl sulphate (SDS).  The presence of aromatic groups 
favored the formation of vesicles [44].  
All cationic surfactants from series 15 with X=Cl showed potent antibacterial activity 
against Gram-positive and Gram-negative bacteria. Optimum results were obtained with 
an alkyl chain length of 10 to 14 carbon atoms, particularly against Gram-negative 
bacteria with MIC values of 0.5-5.0 μg/mL.  Compounds with long alkyl chains (n=15 
and 17) maintained activity against Gram-positive bacteria, but did not inhibit the 
growth of Gram-negative bacteria. These amphiphiles showed very low toxicity to 
mammalian cells: HC50 values were in the range of 100-250 μg/mL for short alkyl 
chains and 1000 for long alkyl chains, with almost negligible toxicity against HeLa 
cells. Changing the counterion from chloride to the more hydrophobic organic 
carboxylates enhanced activity against Gram-positive bacteria and fungi, and improved 
biocompatibility toward eukaryotic cells. Moreover, supramolecular assemblies of 
hydrogelator surfactants based on tryptophan (series 15, n=15) and tyrosine 
(compound 16) were used for in situ synthesis of silver nanoparticles to improve their 
antimicrobial performance [45]. Pure compounds only affected the Gram-positive 
bacteria, although it was observed that the combination of bactericidal AgNP within 
self-assemblies of antibacterial surfactant gelators led to the development of soft 
nanocomposites with activity against both Gram-positive and Gram-negative bacteria. 
 
Antimicrobial cationic surfactants from L-phenylalanine and L-tyrosine (Figure 7, 
series 17) were reported by Joodan et al., in which the alkyl chain is linked to the 
carboxylic group of the amino acid through an ester bond [46]. Two different 
methodologies were used to prepare these ester derivatives. Phenylalanine compounds 
with short alkyl chains were prepared by mixing the amino acid with the corresponding 
alcohol with posterior addition of thionyl chloride . Phenylalanine compounds with long 
alkyl chains were synthesized using p-toluene sulfonic acid as a catalyst.  In both series 
of surfactants, the cmc decreased linearly as the hydrophobic alkyl chain lengthened, 
ranging from 3.9 mM for the surfactant with n=7 to 0.007 mM for n=19 (Table 5). 
These cationic surfactants showed good activity toward Gram-positive and low activity 
against Gram-negative bacteria. Their activity increased with the alkyl chain length, 
exhibiting a cut-off effect at C12. The interaction of these surfactants with phospholipid 
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vesicles showed that both electrostatic and hydrophobic interaction between surfactants 




Sodium N-acyl isoleucines were prepared using a mixture of fatty acids obtained from 
coconut, palm, jatropha, karanja and high oleic sunflower oil. These amphoteric 
surfactants showed good surface active and emulsifier properties. Some also presented 
moderate antimicrobial activity [47]. 
 
2.2. Single chain surfactants with two or more amino acids on the polar head 
 
Our group prepared a range of single chain surfactants with two amino acids on the 
polar head. The alkyl chain length and the type of amino acid were varied to explore 
how these structural parameters affect physicochemical properties and antimicrobial 
activity (Figure 8) [48].  
Amphoteric and cationic Nα-Lauroyl arginine dipeptides were prepared from pure 
amino acids (glycine, phenylalanine, glutamic acid and lysine) on a laboratory scale, 
following a four-step procedure (Figure 8, series 18): (1) acylation of N-nitro arginine 
with lauroyl chloride; (2) condensation of the second amino acid by peptide coupling; 
(3) nitrodeprotection and (4) saponification [49]. Nε-lauroyl lysine-lysine (Figure 8, 19, 
LKKM) has also been prepared by our group following a similar chemical protocol 
[40]. LALM (Figure 8, 18), LAKM (Figure 8, 20) and LKKM (Figure 8, 19) each have 
two cationic charges. LALM has one on the arginine guanidine group and the other on 
the lysine ε-amino group. In LAKM the second cationic charge is located on the lysine 
α-amino group. LKKM has both cationic charges situated on the lysine α-amino group. 
 
Long-chain Nα-acyl-L-arginine diamino acid surfactants were also prepared from acid-
hydrolyzed collagen (C8AC-C16AC) (series 21) using a procedure similar to that for the 
pure derivatives. Waste leather trimmings previously hydrolyzed with 6N HCl at 120 ºC 
for 24 hours were the source of collagen amino acids  [48]. 
The cmc of cationic surfactants with two amino acids on the polar head depends on the 
nature of the amino acids (Table 6). Surfactants with two cationic charges presented 
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high cmc values because of their reduced hydrophobicity. As expected, the cmc values 
of the amphoteric surfactants were lower than those of their cationic homologues. The 
micellization ability of surfactants prepared with hydrolysed collagen was very 
pronounced, which was ascribed to synergic effects between the different lipopeptides 
in the mixture.  
TABLE 6 
Table 7 shows the MIC values obtained for N-acyl derivatives with two amino acids on 
the polar head [49,40]. It can be observed that the amino acid sequence modulated the 
activity. While Nα-lauroyl-arginine methyl ester and other homologous cationic 
surfactants (LAM, series 1) showed good antimicrobial behaviour (Table 2), the 
corresponding amphoteric N-lauroyl-arginine (LAS, series 4) was not active. However, 
when a neutral amino acid was incorporated into N-lauroyl-arginine, carboxylic 
protection was not necessary. In fact, the cationic LAGOM and LAPOM (series 18) 
showed similar antimicrobial activity to their amphoteric homologues LAGOH and 
LAPOH (series 18) (Table 7). The second non polar amino acid avoids electrostatic 
interaction between the guanidine and the carboxylic group, leaving the cationic charge 
of the guanidine free. Activity was drastically reduced by the incorporation of glutamic 
acid (LAGuOM and LAGuOH, series 18); in this case, the guanidine group can react 
with the β-carboxylic group of the glutamic acid, neutralizing the cationic charge of the 
molecule. The addition of lysine as a second amino acid also reduced antimicrobial 
activity (LALM series 18, LAKM 20). The presence of two cationic charges on the 
polar head increases the hydrophilic character of the molecule and consequently reduces 
surface tension and biocide activity. The combination of two lysine amino acids 
(LKKM) was less effective than combing an arginine with a basic or neutral amino acid, 
particularly in the compound with two cationic charges on the two lysine α-amino 
groups The best activity was obtained with the arginine-phenylalanine sequence 
(LAPOM, LAPOH, series 18), perhaps due to the combination of the aromatic ring with 
the charged guanidine group. On the other hand, the Nα-acyl derivatives in which the 
second amino acid came from hydrolysed collagen showed only moderate antimicrobial 




These results indicate that the amino acid sequence, the physicochemical properties of 
the molecule and the cationic charge density are parameters that significantly affect the 
antimicrobial properties of these types of surfactants. 
Potent antimicrobial and antifungal agents consisting of one alkyl chain of 16 carbon 
atoms and two, three and four amino acids have been reported (Figure 9, series 22) [50]. 
Shai et al. showed that each of these palmitoyl-lipopeptides assemble in solution into 
nanostructures with different morphologies, which could partially explain the changes 
in their antimicrobial activity.  The introduction of one alkyl chain into inactive cationic 
tetra- or tripeptides gave rise to powerful antimicrobial and antifungal compounds. Cell 
specificity was determined by the sequence of amino acids on the polar head and the 
length of the aliphatic moiety. For alkyl chains bearing 16 carbon atoms, the lysine-
lysine-lysine sequence showed the highest antimicrobial activity towards all tested 
bacteria with MIC values lower than 15 μM. The lysine-alanine-lysine sequence was 
completely inactive against all tested cells, lysine-leucine-lysine was active only 
towards Gram-positive bacteria and lysine-glycine-lysine showed activity against all 
tested microorganisms. The lysine-glycine-glycine-lysine sequence combined with a 
palmitoyl alkyl chain was the most active tetrapeptide derivative. The biological activity 
remained similar when an L-amino acid was substituted by its D-enantiomer.  
Interestingly, it was observed that the mode of action of these compounds involves 
membrane permeation and disintegration. In contrast with most known AMPs or natural 
lipopeptides, which are active either only on bacteria or on fungi, several compounds of 
this family were very active against both. Further, most of these derivatives were 
practically not haemolytic at their MICs or at higher concentrations [51]. Serrano et al. 
later showed that replacing the α-amino acids by β-aminoacids did not affect the activity 
of the corresponding lipopeptide [52].  
Using solid phase synthesis, Lohan et al. designed and prepared short lipopeptide 
molecules consisting of ornithine units conjugated with fatty acids (series 23, Figure 
10) [53]. Compounds with ornithine residues ranging from 2 to 5 units and alkyl chain 
lengths from C12 to C18 showed very good antimicrobial activity against fungi as well as 
both Gram-positive and Gram-negative bacteria, including clinically relevant 
methicillin-resistant S. aureus and S. epidermis (MRSA and MRSE), which are resistant 
to most antibiotics. Among the synthesized compounds, the most active was a 
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lipopeptide composed of three ornithines bearing one C14 alkyl chain. This compound 
showed potent activity with MIC values of 1.5 µg/mL for E. coli, P. aeruginosa, and S. 
aureus, 6.25 µg/mL for B. subtilis, 6.24 µg/mL for MRSE and 12.5 µg/mL for MRSA. 
All these ornithine derivatives presented low haemolytic activity, with HC50 values 
higher than 250 µg/mL. The results indicate that these compounds are able to kill 
microbes without any lytic activity towards mammalian erythrocytes. 
Antimicrobial dipeptide-based amphiphiles with varying head group structures were 
also obtained by Das et al., featuring different combinations of three amino acids: 
phenylalanine, proline and tryptophan (Figure 11, 24, 25, 26, 27, 28, 29) [54]. In a 
multistep synthesis, Boc-protected amino acids were coupled with the methyl ester of 
the corresponding L-amino acids using dicyclohexylcarbodiimide (DCC) and a catalytic 
amount of dimethylaminopyridine (DMAP) in the presence of N-hydroxybenzotriazole 
(HOBT). After purification, this intermediate was subjected to saponification by the 
addition of Na(OH). The free carboxylic group was then coupled with n-
tetradecylamine using DCC and a catalytic amount of DMAP in the presence of HOBT. 
Finally, the BOC-protected group was removed with trifluoroacetic acid. 
These amphiphiles presented notable hydrogelation efficiency at a wide range of 
minimum gelation concentrations (MGC=1.2-22%) and marked growth inhibition of 
both Gram-positive (MIC values between 1-50 µg/mL) and Gram-negative bacteria 
(MIC values between 5-150 µg/mL) as well as fungus (MIC values between 1-50 
µg/mL). The most active compounds were those with Phe-Pro (24) and Trp-Pro (26) in 
the head group. The effect of these amphiphiles on the morphology of bacterial cells 
was studied using scanning electron microscopy. The SEM images showed collapse in 
the membrane integrity of lysed E.coli and S. aureus while remaining intact in untreated 
bacteria. Interestingly, the cytotoxicity of all the dipeptide-based amphiphiles against 
human cancer-derived HepG2 cells and human cervical cancer-derived SiHa and HeLa 
cells was very low. In fact, a maximum of only 36% cytotoxicity against HeLa cells was 
observed in compound 26 at a concentration of 200 µg/mL. 
Linoleic acid-dipeptide-spermidine conjugates have also been proposed as antimicrobial 
agents (30, 31, 32). These amphiphiles contained linoleic or stearic acid linked to a 
polyamine polar head combining two amino acids (tryptophan and ornithine) 
conjugated with spermidine [55]. The hydrophobic tryptophan amino acid was chosen 
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because of its membrane-anchoring property [56] and ornithine was used to impart 
protease stability to the amphiphiles due to its non-ribosomal origin.  The sequences 
were synthesized using a combined solid phase and solution phase strategy involving 
several steps. Briefly, the dipeptides were prepared on a solid support using Fmoc 
chemistry. Then the condensation between the fatty acid and the dipeptide was achieved 
using HOBT and N,N'-diisopropylcarbodiimide (DIPCDI). Finally, the N1,N4-
bis(boc)spermidine was linked to the carboxylic group of the dipeptide, also using 
HOBT and DIPCID in a solution of dry tetrahydrofuran. 
Intermediates containing only the dipeptide with spermidine did not show antimicrobial 
activity, while those without the spermidine residue (peptide+fatty acid) inhibited 
bacterial growth only to a low extent. Sequences containing long alkyl chains (linoleic 
or stearic acid) and spermidine exhibited potent activity against susceptible and drug 
resistant Gram-positive and Gram-negative bacterial strains as well as rapid bactericidal 
kinetics. Against E. coli and P. aeruginosa, MIC values of these amphiphiles were in 
the range of 3.5-28.4 µg/mL and 7.1-14.2 µg/mL, respectively. Against the four Gram-
positive strains tested, the MIC values were below 15 µg/mL. These data revealed that 
to obtain efficient antimicrobial compounds, a hydrophobicity window combined with a 
determined number of cationic charges is crucial. In general, the mode of action of these 
amphiphiles involved disruption of the bacterial membrane. However, they were also 
able to alter the electrophoretic mobility of DNA, which may also have enhanced the 
activity of these sequences. The dipeptide sequence played a predominant role in the 
mode of action. At MIC, compound 30 showed low membrane leakage and 
depolarization. It reduced DNA binding ability, suggesting that membrane 
destabilization is a less probable mode of action and that other vital functions in 
bacterial cells could be affected. However, at a higher concentration, a membrane 
disruptive mode of action was evident. Compound 31 clearly induced membrane 
perturbance, while compound 32 showed rapid bactericidal kinetics, causing moderate 
levels of leakage. This behaviour was ascribed to the formation of transient pores or 
pores not large enough to cause much leakage. Also remarkable was the low haemolytic 
activity of these compounds, most of them being non-haemolytic up to 62 µg/mL. 
Additionally, results of the MTT assay in HaCaT cells showed more than 80% cell 
survival at 62 µg/mL. 
22 
 
As this summary indicates, the combination of two or three amino acids on the 
surfactant polar heads can create very effective antimicrobial agents. Their potency 
increases when the peptide sequence contains an aromatic amino acid such as 
tryptophan, combined with another with a cationic charge. Arg and Trp are found in 
unusually high proportions in numerous antimicrobial peptides. Apart from their 
positive charge, the specific properties that these amino acids bring to antimicrobial 
peptides are still unclear. The aromatic indole side chain has an extensive π-electron 
system that gives rise to a significant quadruple moment, which can be considered as 
two dipole moments extending perpendicularly out of either side of the ring plane. The 
π-electron system of Tryptophan or other amino acids with aromatic groups results in 
negatively charged clouds that can participate in cation-π interactions between this 
negatively charged electron cloud and positively charged side chains of arginine [57]. 
These cationic-π interactions make the entry of arginine into the hydrophobic 
environment inside a lipid bilayer energetically more favourable. Moreover, when the 
Arginine residue is involved in these cationic-π interactions, hydrogen bonds can still be 
formed. The cationic charge of amino acids enhances the attraction of peptides or 
antimicrobial agents to the membranes, and hydrogen bonding promotes interaction 
with negatively charged surfaces such as LPS or phosphatidylglycerol phospholipid 
head groups. On the other hand, it has been reported that Tryptophan residues have a 
preference for the interfacial region of lipid bilayers [58] the large indole side chain 
disrupting the cohesive hydrophobic interactions of the lipid acyl chains when it buries 
deeper into the hydrocarbon core of a lipid bilayer. Because of that, it has been 
proposed that the complex electrostatic nature of the interfacial region of the lipid 
bilayers is ideal to accommodate Tryptophan residues. Overall, the combination of the 
cationic charge of amino acids with the special properties of Tryptophan or other 
aromatic amino acids seems to improve the antimicrobial properties of peptides [59].  
 
2.3.Double chain surfactants 
2.3.1 Glycerolipidic structures 




Arginine glycerolipid conjugates constitute a novel class of lipoamino acids, which can 
be considered analogues of partial glycerides and phospholipids (Figure 12, series 34). 
They consist of two aliphatic chains and one amino acid on the polar head, linked by a 
glycerol moiety (Fig12, series 35 and 36).  
 
Structurally, these compounds have a central skeleton of glycerol that links the 
hydrophobic part, formed by two fatty chains of variable length, to the hydrophilic part, 
formed by arginine or acetyl-arginine linked to the glycerol by its terminal hydroxyl 
through an ester bond [60,61]. This family of compounds combines in one molecule the 
physicochemical properties of glycero derivatives and polar arginine-based surfactants, 
conferring certain advantages over conventional phospholipids: a) the introduction of 
arginine in the polar head increases their solubility in aqueous solution; b) the cationic 
characteristics associated with arginine endow the amphiphilic molecule with 
antimicrobial activity and c) the fatty chains allow the molecule to aggregate 
spontaneously in water. 
The synthesis of the XXR compounds (Figure 12, series 35) was successfully achieved 
following a three-step chemical procedure [60], starting from commercially available N-
Cbz-L-arginine-rac-glycerol.HCl. The first step was to bind the glycerol and the 
protected arginine via chemical esterification of the arginine α-carboxyl group with the 
primary hydroxyl function of glycerol. The second step was the acylation of the two 
remaining free hydroxyl groups with the corresponding long-chain acid chlorides. The 
third and last step was the catalytic hydrogenation of the arginine protecting group using 
Pd over charcoal. The following compounds were obtained: 88R, 1010R, 1212R and 
1414R (series 35). 
The compounds XXRAc (Figure 12, series 36) were synthesized using chemical and 
enzymatic methodologies [61b]. Both methods have in common the first stage of the 
synthesis, which is the enzymatic preparation of the arginine glyceryl ester derivative. 
This reaction consisted of the selective protease-catalysed esterification of one of the 
primary hydroxyl groups of the glycerol with the arginine carboxylate group. The 
second step involved the preparation of XXRAc compounds by chemical or enzymatic 
acylation of the two remaining free hydroxyl groups with the corresponding long-chain 
acid chloride  
The surfactant phase behaviour is largely dependent on the packing possibilities of the 
molecules [62]. As XXR and XXRAc bear two hydrophobic chains, they have a larger 
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cross section than single chain surfactants and, based on simple packing restrictions, the 
preferred packing will obviously be in the form of flat structures. This has a 
concomitant effect on a small critical micellar concentration, the formation of vesicles 
at low concentration in water and the formation of lamellar liquid crystals at a high 
concentration. When the cmc of the XXR (series 35) compounds was systematically 
studied, a large discrepancy between methods was apparent [63]. Conductivity and 
fluorescence gave values of 5 mM and 7 mM for 88R, while a value of only 0.07 mM 
was obtained from surface tension (Table 8). This disparity was attributed to the 
formation of premicellar aggregates. Further studies established that the low value 
obtained by surface tension was due to the formation of vesicles at very low 
concentrations [64]. The cmc values of the XXR and XXRAc compounds differed from 
short-chain lecithins. Short chain phospholipids aggregate in water, forming micelles at 
concentrations of about 16.5 mM for diC6 -lecithin and 0.24 mM for diC8 –lecithin [65]. 
The cmc values of arginine diacyl-glycerolipid conjugates with the same fatty chain 
length (Table 8) are one order of magnitude higher, which can be attributed to a higher 
solubility.  
TABLE 8 
Spread monolayers of two compounds of the XXRAc family, 1212RAc and 1414RAc 
(series 36), were studied alone [66] and in mixtures with 1,2-dimiristoyl-phosphatidyl 
choline (DMPC) and 1,2-palmitoyl-phosphatidyl choline (DPPC) [67]. Interactions 
between components in mixed monolayers were studied from the point of view of their 
miscibility. All mixtures presented partial miscibility between the two components, and 
the monolayer was thermodynamically favoured, with the exception of 
1212RAc/DMPC. 
 
2.3.2. Double chain surfactants from lysine 
Lysine-bisglycidol conjugates are lysine-based cationic amphiphilic molecules that 
combine several hydroxyl functions and aliphatic chains with 12 or 14 carbon atoms 
(Figure 13, series 37, 38, 39) [68].  
 
These molecules show two main features: a lysine methyl ester residue as the polar 
group, which confers a cationic character to the molecule and is linked to a bisglycidol 
chain, and a residue of bis(2,3-dihydroxypropyl), which can carry from one to four 
aliphatic chains as part of the hydrophobic moiety. In addition, the lysine group is 
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bonded to the polyol skeleton through an N-alkyl amine, which increases chemical 
stability compared to the diacyl-glycerol arginine derivatives. One important drawback 
of the classical cationic surfactants is their low biodegradability in aerobic conditions 
due to the N-C linkage between the alkyl chain and the cationic group. In lysine-
bisglycidol, the presence of an ester-type linkage between the hydrophilic moiety and 
the hydrophobic backbone ensures high biodegradability. 
The synthesis of these compounds involved four steps: (1) esterification of the protected 
lysine, (2) aminoxylation of the esterified lysine with an excess of glycidol, (3) 
esterification of the hydroxyl functions with fatty acyl chlorides and (4) deprotection of 
lysine by catalytic hydrogenation to obtain the final compounds. The key step of this 
synthetic strategy is the reaction between the protected lysine and glycidol, which is 
easy to perform and guarantees good yields.    
The cmc and critical aggregation concentration were determined by surface tension, 
conductivity, and chloride ion activity. Based on conductivity and chloride ion activity, 
the cmc of the double-chain LGGdi12 and LGGdi14 (series 38) were 0.5 and 0.4 M, 
respectively. The most striking feature of the cmc values is the great disparity between 
those obtained by surface tension compared with the other two techniques. Such 
discrepancy between interface and bulk techniques in the determination of cmc/cac is 




The arginine diacyl-glycerolipid conjugates as well as the lysine bisglycidol derivatives 
showed antimicrobial activity against a wide range of microorganisms, including Gram-
negative bacteria (Table 9) [60,68]. Among the XXR (series 35) surfactants, the 
maximum activity corresponded to the compound with 8 carbon atoms in the alkyl 
chains, the activity decreasing with longer alkyl chains. The most active dyglyceride 
derivative (88R, series 35) performed similarly to LAM or LAE (series 1), the most 
active Nα-acyl-arginine surfactants. It should be taken into account that 88R (series 35) 
and LAM (series 1) had a similar cmc and the cationic charge in both surfactants lay in 
a guanidine group. Thus, two of the parameters that control antimicrobial behaviour, 
hydrophobic-hydrophilic balance and charge density, were similar in the two 
compounds. The XXRAc (series 36) derivatives showed slightly more activity than 
their corresponding homologues, 1212R and 1414R (series 35) [61]. Antimicrobial 
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properties can be enhanced by increasing the number of cationic charges on the polar 
head, so the XXR surfactants could be expected to be more active. However, the 1212R 
has the second cationic charge on the α-amino group of arginine and this group is not 
protonated at pH=7.2 (Muller Hinton medium). Moreover, the solubility of XXRAc is 
slightly higher than that of the corresponding XXR homologue; it seems that the 
hydrophilic character of XXRAc was enhanced by the incorporation of the amide bond, 
which can easily form hydrogen bonds. The lysine derivative LGGdi12 (series 38) also 
showed greater activity than 1212R (series 35), its two free hydroxyl groups providing 
solubility. The HC50 values of the XXR (series 35) derivatives were higher than those 
of typical cationic surfactants based on quaternary ammonium groups. In this surfactant 
family, the haemolytic activity decreased when the hydrophobicity of the molecules 
increased. In fact, 88R exhibited an HC50 value of 24 μg/mL, while the HC50 of 1414R 
was 64.3 μg/mL [60]. 
Double chain cationic lysine-based surfactants were also synthesized via solid phase 
peptide synthesis and terminal acylation of their α and ε positions with saturated fatty 
acids [70]. Four lipopeptides of Nα-acyl-Nε-acyl lysine-type were prepared (Figure 14, 
series 40) [71]. 
TABLE 10 
 
The cmc and surface tension values at cmc are summarized in Table 10. As expected, 
the cmc strongly depended on the length of the hydrophobic chains attached to the α and 
ε amino groups. High surface tension values at cmc (γcmc) were observed for these 
surfactants, and they increased slightly when the alkyl chain was lengthened. 
 
For this surfactant family, the best antimicrobial activity was found in compounds with 
alkyl chains of 10 and 12 carbon atoms. (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2 
showed high biocide activity against Gram-positive and Gram-negative bacteria with 
MIC values in the range of 2-64 mg/L. Optimum activity was obtained in derivatives 
with alkyl chains of 10-12 carbon atoms, in contrast with 8-10 in double chain arginine-
based surfactants. As these compounds contain a big polar head with four basic amino 
acids, longer alkyl chains are required to obtain an appropriate hydrophobic-hydrophilic 
balance. The antifungal activity of these compounds was much weaker, with MIC 
values in the range of 128-256 mg/L. It was also observed that the antifungal activity 
was not influenced by the alkyl chain length.. All these compounds, at concentrations of 
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2 mg/L, caused haemolysis <3%. Above this concentration, the increase in haemolysis 
depended on the alkyl chain length, the most toxic being (C12)2-KKKK-NH2. 
Ahn et al. [72] prepared double chain surfactants in which the polar head consisted of 
one histidine with one or two arginines, and the hydrophobic part contained two alkyl 
chains linked to the imidazole group (series 41a, Figure 15). These surfactants 
possessed one positive charge on the imidazole group and two guanidine groups that 
can be protonated. Single chain derivatives with only one alkyl chain were also 
synthesized (series 41b, Figure 15). 
The double chain homologues with n=5 and n=8 displayed potent antimicrobial activity 
against Gram-negative and Gram-positive bacteria (average MIC range of 3.7-24.0 
mg/L). However, the compound with C14 pendant alkyl chains completely lost these 
antimicrobial properties. The monoalkylated compound showed similar high activity 
towards Gram-positive bacteria, but it decreased 2-4 fold against all Gram-negative 
strains. In addition, these compounds retained their activity against methicillin-resistant 
strains. By microscopy, it was observed that bacteria treated with these surfactants, at a 
concentration of 3 times the MIC, showed clear rupturing of cells, with release of 
internal materials. Interestingly, all these derivatives displayed low haemolytic power, 
with an HC50 higher than 100 mg/L. 
2.3.3. GEMINI SURFACTANTS 
Dimeric or gemini surfactants are a class of surface active agents composed of two 
single surfactants chemically linked at or near the head groups by a rigid or flexible 
spacer chain. Due to the greater amount of hydrocarbon per molecule, the cmc of 
gemini are typically one order of magnitude lower than of the corresponding monomeric 
surfactant. They are ten to a hundred times more efficient at reducing the surface 
tension of water and the interfacial tension than conventional surfactants.  
Consequently, the application of only small amounts of gemini surfactants can produce 
great effects. 
Cationic gemini surfactants from cystine 
The amino acid cystine consists of two cysteine residues joined by a disulphide linkage 
and offers a potential material for the synthesis of gemini surfactants. One cationic 
gemini surfactants from cystine were prepared by Pinazo et al. [73]. This compound had 
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two saturated hydrocarbon chains and a complex polar group consisting of two 
quaternary ammonium salts linked through an alkene spacer chain containing amide and 
disulfide bonds (compound 42, Figure16).  
 
This surfactant were prepared by condensation of commercial N-lauryl N,N-dimethyl 
amino betaine with a cystine dimethyl ester using the mixed anhydride method. Cystine 
was the source of the disulfide function. The cystine-based gemini surfactant showed 
very low cmc, 21x10-6 M, and moderate to good adsorption efficacy with surface 
tension at the cmc of 35 mNm-1. Also, the estimated area per molecule for dialkyl 
surfactants was reasonable at 1nm2. Further studies with products of somewhat lower 
purity (alleged presence of partial monoalkyl derivatives) produced significantly higher 
cmc values (65x10-6 M) [74]. The pulsating bubble technique showed that the dynamics 
of adsorption of these gemini surfactants is slower than the diffusion.  
 
Cationic gemini surfactants from arginine 
 
Cationic gemini surfactants from arginine, bis(Args) were reported by Perez et al. [75]. 
The general formula for these compounds is shown in Figure 17, series 43. They consist 
of double chain amphiphiles with two hydrophilic chiral head groups from the natural 
amino acid L-Arg and a polymethylene spacer chain of variable length. The fatty chain 
is connected through an amide bond to the arginine Namino group.  
The initial synthetic approach involved chemical protecting groups, deprotection 
reactions and chemical catalysis. This efficient method enabled a large number of 
homologues to be easily prepared. The second approach involved chemo-enzymatic 
strategies [76], in which one amino group of the diaminoalkane spacer underwent 
quantitative acylation by the carboxylic ethyl ester of the Nα-acyl–arginine, followed by 
a papain-catalyzed reaction between Nα-acyl–arginine and the unreacted amino group of 
the diaminoalkane spacer. Compounds with different alkyl chain lengths, as well as 
different spacers, were prepared. 
 
Table 11 shows the cmc and surface tension at the cmc for gemini surfactants and their 
corresponding single chain counterpart LAM (series 1). The most striking feature is the 
very low values of cmc, in the range of a few micromoles per liter, and also the 
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considerable difference (three orders of magnitude) compared with the single chain 
compound [77].  
TABLE 11 
 
Cationic gemini surfactants from lysine 
Four gemini surfactants from lysine (series 44, Figure 18) were prepared, varying the 
spacer chain and the number and type of cationic charges: two positive charges on the 
ε-amino groups of the lysine and a methylene-based spacer chain (C6(LL)2); two 
positive charges on the α-amino groups of lysine and a methylene-based spacer chain 
(C6(LK)2); two positive charges on the two trimethylated α-amino groups of the 
quaternised lysine and a methylene-based spacer chain ( C6(LK)2Q); and finally, a 
spermidine-based spacer and two positive charges on the α-amino groups of lysine as 
well as a third positive charge on the spacer chain (C7NH(LK)2) 
 [78]. 
The surfactants were obtained on a multigram scale with 99% purity by chemical 
condensation of the single long-chain N-lauroyl-L-lisine, previously protected, to the 
corresponding spacer in the presence of an activating agent. A final deprotection 
reaction was carried out to obtain the desired cationic gemini compounds. As expected, 
their cmc values were roughly two orders of magnitude lower than the monocatenary 
homologue. CMC values of α- and ε-linked lysine differed only slightly, at 740 and 
500 micromolar, respectively, despite the considerable structural changes involved. 
Asymmetric cationic gemini surfactant analogues from lysine, with two quaternary 
ammonium groups linked to the fluorinated or hydrocarbon alkyl chains through amide 
bonds and a lysine spacer (Series 45, Figure 19), were prepared by Tan et al. [79].  
 
Antimicrobial properties of gemini surfactants 
Overall, the antimicrobial activity of the gemini surfactants was higher than of their 
monocatenary counterparts. This was due to several structural and functional features, 
since the mechanism of action was based on the surface-active properties of the 
compound. 
The antimicrobial behavior of compound 42 was evaluated against a wide range of 
microorganisms, including Gram-positive and Gram-negative bacteria. Excellent 
activity was displayed against all the microorganisms with MIC values from 0.125 to 16 
μg/mL [80].  
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Gemini surfactants from lysine and arginine also exhibited antimicrobial activity against 
a broad spectrum of Gram-positive and Gram-negative bacteria. Several features 
affected the antimicrobial activity of amino acid gemini surfactants [81, 40]: i) the 
length of the spacer alkyl chain (Table 12), ii) the length of the alkyl chain (Table 13) 
and iii) the type of amino group where the cationic charge is located (Table 14). 
 
TABLE 12, 13, 14 
 
Keeping the alkyl chain constant (x= 8), the antimicrobial activity decreased with long 
spacer chains (n=9, n=10), the most favorable being n=3 (Table 12). This behavior 
could be ascribed to aggregate size, gemini with short spacers tend to form spherical 
micelles while those with large spacers form viscous solutions that contain big three like 
micelles [82]. The second main feature affecting the antimicrobial activity is the alkyl 
chain length. The best performing gemini surfactant had alkyl chains of ten carbon 
atoms (C3(CA)2, series 43, Table 13), while those with 8 carbon atoms (C3(OA)2, series 
43) showed negligible activity, probably due to high hydrophilicity. Devinsky et al. also 
found that the antimicrobial performance of bisquat-type gemini surfactants is optimum 
in the range of 10 to 12 carbon atoms [83]. In general, arginine-based gemini surfactants 
are more antimicrobial than monomeric compounds. For example, the most active one, 
C3(CA)2 (series 43), performed better than LAM (Table 2), the most active 
monocatenary surfactant. 
 
The net cationic charge of the molecules is the third structural feature that significantly 
affects activity against bacteria (Table 14), which increases with the pKa value [40]. 
Keeping the alkyl chain (12C) and the spacer (6C) the best performance was obtained 
with C6(LK)2Q (series 44) (fixed positive charges) and C6(LA)2 (series 43) (cationic 
charges situated on the guanidine group, pKa>10). The least active surfactant, C6(LK)2 
(series 44) had the positive charge located on the α-protonated amine group of lysine 
(pKa about 6). These means that the average charge of C6(LK)2 at the pH of the medium 
used to determine the MIC values could be lower than 2 charges per molecule. The MIC 
values obtained for these compounds at different pH values confirmed that the net 
positive charge affected the antimicrobial activity. In fact, it was observed that the 
activity of compounds with pKa values lower than 7 increases as the pH decreases [40]. 
Rosin et al. prepared cationic gemini surfactants with four cationic charges structurally 
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analogous to C6(LL)2. The spacer chain consisted of spermine and consequently 
contained two positively charged amino groups, and the alkyl chains were substituted 
by cholyl groups [84]. The results indicate that this surfactant was more active than 
C6(LA)2.  
 
To assess the effect of C3(CA)2 (series 43) on bacterial populations, flow cytometry 
analysis were performed using dual staining with SYTO-13, a fluorochrome that 
penetrates the cell binding to DNA, and propidium iodure (PI), a stain not taken up by 
intact cells, but which penetrates the cell when the membrane is permeabilized [85]. As 
shown in Fig. 20, in both cases the control population was stained with SYTO-13; in the 
case of the Gram-positive S. aureus, after treatment with C3(CA)2 at 2/3MIC, still most 
of the population (95%) remained intact, 2% was double-stained, suggesting partial 
damage, and only 3% appeared as dead cells (stained with PI). E. coli. displayed a 
different reaction: after treatment at sub-MIC (2/3MIC), most of the population was 
stained with PI, indicating the cells had been killed by membrane permeabilization.  
Electron micrographs supported these results. In S. aureus, C3(CA)2 induced the 
formation of mesomes and cytoplasmic clear zones, but the loss of membrane integrity 
was lower than in E. coli (Figure 21). 
Although MIC values for the lysine-based gemini surfactants (Table 14) were lower 
than for those with arginine (Table 12,13), they also induced critical damage in bacteria. 
Electron micrographs of bacteria treated with C6(LL)2 (series 44) confirmed that the 
gemini mode of action involved a drastic damage to the gram-positive S. aureus and 
gram-negative E. coli (Fig. 21 b). A clear disruption of the cellular membrane and 
incipient solubilization of the cytoplasm material (white areas) was observed. Cell 
fragments with a complete collapse of the membrane also appeared in the background 
of the micrograph [41]. 
 
The antimicrobial and antifungal properties of asymmetric cationic gemini surfactants 
from lysine (series 45) were studied using bacteria, both gram-positive (S. aureus) and 
gram-negative (E. coli), as well as yeast (C. albicans) and mould (Aspergillus niger). 
The MIC values (2-62.5 µM) were in all cases lower than those of DTAB. The 
homologue with alkyl chains of ten carbon atoms was again the most active compound 




The results reported indicated that, in general, cationic gemini surfactants from amino 
acids show greater antimicrobial activity than their monocatenary homologues, possibly 
due to a combination of factors: i) low cmc values, ii) good solubility and the presence 
of two positive charges and iii) two alkyl chains per molecule. Indeed, the introduction 
of additional positive charges on the spacer chain increased their action. The alkyl chain 
length affected the antimicrobial activity in the same way as in monocatenary 
surfactants. In the case of gemini surfactants, optimum activity was obtained with alkyl 
chains of 10 carbon atoms, while in single chain surfactants, those of 12-14 carbon 
atoms gave the lowest MIC values.   
Regarding haemolytic activity, antimicrobial gemini surfactants from lysine and 
arginine have generally shown a higher capacity to disrupt erythrocyte membranes than 
their single chain homologues [40,32]. For example, the HC50 of C3(CA)2 and C3(LA)2 
(series 43) was 48.1 and 12.5 mg/L, while their single chain homologues, CAM and 
LAM (series 1), exhibited HC50 values of 58.8 and 38.5, respectively. It was also 
observed that the haemolytic activity was enhanced by lengthening the alkyl chain 
(HC50 of C3(OA)2>1000mg/L and HC50 of C3(LA)2 12.5 mg/L)  and for the same alkyl 
chain the haemolysis increased by increasing the spacer length or the cationic charge 
density of the molecule [40]. However, the size of aggregates in the solution also 
affected haemolysis. The less active C12(LA)2 and C9(LA)2 had two alkyl chains in very 
close proximity, resulting in the formation of large aggregates in aqueous solution, 
which hampered interaction with biological membranes [86].  
The haemolytic power of lysine- and arginine-derived gemini surfactants differs 
considerably from those based on quaternary ammonium (bis(Quats) [87]. While the 
amino acid-based gemini surfactants showed hemolytic activity at 9-400 mg/L,[32,40] 
bis(Quats) were able to lyse red blood cells at very low concentrations (0.05-0.1 mg/L) 
[87]. Moreover, bisArgs cytotoxicity against cutaneous cells corroborates the trend 
observed in the haemolysis assay. The IC50 values obtained using fibroblasts range from 
21.9 mg/L for C3(LA)2 to 341 mg/L for C3(OA)2. Similar results were obtained using 
keratynocytes [32]. 
The acute toxicity determined against D. magna crustaceus  and bioluminescent marine 
bacteria P. phosphoreum indicated that whereas quats have IC50 and EC50 <1ppm the 
amino acid gemini surfactants are in the range of 2-30 ppm. Analysis of biodegradation, 
measured as % total organic carbon removal, showed that these gemini surfactants with 
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a spacer chain of 3 to 6 carbon atoms are readily biodegradable [88]. The degradation of 
these surfactants yielded fatty acids, alkyldiamine, and amino acids, none of which are 
hazardous from either the toxicological or ecological standpoint. 
3. Other Applications 
Cationic surfactants from amino acids, easily prepared from renewable raw materials, 
have a myriad of applications besides that of antimicrobial agents, due to their surface 
activity. In an attempt to explore the potential uses of arginine-glycerol-based 
compounds in clinical settings, a formulation strategy to decrease their cytotoxicity was 
developed. The most likely option was to tune their charge density by formulation with 
phosphatidylglycerol (PG) as catanionic vesicles and with dipalmitoyl 
phosphatidylcholine (DPPC) as cationic vesicles. Formulating the compounds 1212R, 
1414R, 1212RAc and 1414RAc (series 35, 36) as negatively charged catanionic 
vesicles drastically reduced their cytotoxicity [89].  
Even today, Gram-negative sepsis is an important health problem with high mortality.  
The absence of specific and effective therapy can result in septic shock. Sunil et al. 
studied whether bisArgs C3(LA)2 and C6(LA)2 (series 43)  could act as endotoxin 
sequestering agents. These gemini surfactants bind bacterial lipopolysaccharides (LPS) 
and neutralize endotoxic activity in vitro (tumor necrosis factor-α and nitric oxide 
release assays), but are cytotoxic by virtue of being membrane-active. The development 
of less surface-active analogues may yield potentially therapeutically useful compounds 
for the treatment of Gram-negative sepsis [90]. 
Glycerolipid surfactants from arginine are potential candidates for drug delivery. 
Cationic vesicles prepared with pure glycerolipidic-arginine-based surfactants or 
mixtures of these compounds with DPPC were found to be stable, and the average 
diameter of the vesicles decreased with increasing alkyl chain length. These vesicles 
were able to encapsulate drugs such as Ciprofloxacin and 5-Fluorouracil (5-FU),. The 
percentage of encapsulated drug depended on the physicochemical properties of the 
vesicle size and the nature of the drug. The in vitro release from these formulations was 
delayed with respect to the corresponding free drug solutions. It was observed that these 
cationic vesicles showed antimicrobial activity. Moreover the ciprofloxacin 
encapsulated in these vesicles preserved its antimicrobial activity. Interestingly, these 
formulations showed two pharmacological functions: one related to the nature of the 
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encapsulated drugs and the other related to the innate antibacterial properties of the 
surfactant-based carriers [91]. 
An important factor for surfactant application in living systems is the kinetics of 
adsorption. The rate of adsorption of insoluble phospholipids at surfaces is slow and 
depends on their state of dispersion. Small vesicles reduce surface tension faster than 
bigger and multilayered structures. A strong synergistic adsorption was found after the 
addition of small amounts of 1414RAc (series 36) to DPPC [92].  
A synergistic formulation between the cationic amino acid surfactant MKM (series 6) 
and the hyaluronic acid (HA) biopolymer was developed to be used as a coating for 
viscose fabric (CV). The interaction studies showed that the MKM and HA formed a 
complex with a slightly positive charge at neutral pH due to the excess of MKM to HA 
binding sites.  
The precipitated complex adsorbs to the fabric to a greater extent than HA or MKM 
individually, and remains on the fabric surface even after rinsing. The samples of CV 
treated only with HA or MKM showed a reduction rate of pathogenic microorganisms 
similar to the pre-treated CV because the coating was washed out during the rinsing 
step. However, samples treated with the HA-MKM complex exhibited excellent 
antimicrobial properties against Gram-positive and Gram-negative bacteria and fungi 
(Table 15). These kinds of functionalized fibers could find applications in several fields 
as wound-healing and medical textiles [93]. 
TABLE 15 
Additionally, the disulphide bond constitutes a potential reactive group able to react 
with thiol groups of reduced keratin fibers by a thiol/disulphide interchange reaction, 
providing a covalently bound substrate for the attachment of anionic dye molecules  
[94]. Gemini cationic surfactants based on cystine and cystamine (series 42) have been 
reported as amphiphilic molecules specifically designed to permanently affect keratin 
fibers by an adsorption/reaction process. The effectiveness of this NN’-bis (N dodecyl-
N,N-dimethyl) cystamine glycine dihydrochloride (42, DABC) was assessed on wool 
fabric by scanning electron microscopy; after treatment with DABC, the wool fibers 
remained free/clean of bacteria, both S. aureus and E. coli, as shown in Figure 22. The 
treated fabric acquired a new property, inhibiting bacterial growth by 99.9% and 99.6%, 




Recently, cationic colloidal systems of Cn(XA)2 (series 43) surfactants and membrane 
additive compounds such as dilauroyl  phosphatidyl choline or cholesterol have been 
studied. Formulations prepared with pure Cn(XA)2 or Cn(XA)2/DLPC mixtures contain 
big cationic aggregates with positive zeta-potential and high colloidal stability. It 
appears that the antimicrobial activity greatly depends on aggregate size, increasing as 
the size diminished [82].  
Cationic amino acid-based surfactants, particularly gemini compounds, are perfect 
candidates for biomedical applications that require positively charged amphiphiles. In 
fact, most of the compounds described in the literature have been prepared and used as 
new synthetic vectors in gene transfection [96]. 
4. Conclusions 
 
Cationic surfactants based on amino acids can show excellent antimicrobial and 
antifungical properties. The manufacturing cost of these compounds is economically 
viable and, in general, these kinds of surfactants can be considered as readily 
biodegradable compounds. Their antimicrobial activity depends on the 
hydrophilic/lipophilic balance of the molecule, the cationic charge density and the 
amino acid sequence on the polar head. Given their physicochemical and biological 
properties these compounds are good candidates to be used as antimicrobial compounds 
in biomedical and biotechnological applications. 
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(1)Due to the low solubility of this compound, the surface tension/concentration curve was determined 
at 40ºC  
(2)cmc calculated from conductivity measurements. 
(3)These amphoteric compounds showed very low aqueous solubility, making it impossible to determine 




Table 2. Antibacterial activity based on the minimal inhibitory concentration (MIC μg/mL) of single chain arginine-based surfactants 
 
 
      
 
 
CAM LAM LAE MAM ACA ALA AMA AOE ACE ALE 10OR 12OR 14OR 
  
    
 Alkyl chain length   10   12   12   14   10   12   14   8   10  12   10   12   14 





































Staphylococcus epidermidis 128 4 2 128 32 16 16 256 nd 64 128 128 64 
Streptococcus faecalis 128 16 8 nd 32 16 32 256 64 32 128 128 128 





































Klebsiella pneumoniae 256 16 16 256 32 16 >256 256 256 >256 128 64 128 
Citrobacter  freundii 128 32 32 128 64 32 32 128 64 64 256 128 128 
Serratia marcescens >256 128 128 nd 64 32 64 >256 128 64 nd nd nd 
Pseudononas aeruginosa >256 64 64 256 128 64 64 >256 256 128 256 256 64 
Salmonella Typhimurium >256 32 32 256 64 32 32 256 64 >256 nd nd nd 

































Table 3. CMC and pKa values of cationic N-acyl-lysine surfactants 




































Table 4. Minimum inhibitory concentration (MIC μg/mL) of lysine-derived surfactants 
 
 LKM MKM PKM LLM LLE LLS LLMq LLEq MKM Q 
Alkyl chain C12 C14 C16 C12 C12 C12 C12 C12 C14 
(pKa) (6.2) (5.3) (4.5) (8.8)      
Series 6 6 6 7 7 7 8 8 9 
S aureus  128 64 64 32 8 >128 128 8 16 
S. epidermidis 64 64 64 16 4 >128 32 4 8 
Bacillus. subtilis  125 64/16 64 16 8 >128 64 8 16 
B. cereus  var mycoides 64 64 64 64 16 >128 64 16  
Micrococcus  luteus  128 64/16 32 4 8 >128 32 8 16 
Myccobacterium  phlei 64 32 64   >128    
S. faecalis    32 8 >128 64   
Acinetobacter calcoaceticus    32 8 >128 64 8  
Corynebacterium  agropiry    4 2 >128 32   
E. coli  63 64 256 16 8 >128 >128 8 125 
K. pneumoniae  125 128 >256 32 16 >128 64 16 125 
S. marcescens >256 >257 >258 128 32 >128 128 32  
P. aeruginosa  >256 >256 >256 64 128 >128 - 128 >256 
S. tiphymurium >256 >256 >256 32  >128 -   
S. derby     32 >128 >128 128  
C. freundii     32 >128 64/128 64  
B. bronchiseptica >256 >257 >258 16 32 >128 16/128 64  
E. aerogenes >256 >257 >258   >128 -   




Table 5. Critical micellar concentration of cationic single chain surfactants from 







7 3.96 1.94 
9 0.69 0.28 
11 0.15 0.039 
13 0.018 0.014 
15 0.014  
17 0.011  






Table 6. CMC and surface tension at the cmc (γcmc) corresponding to the long-chain N
α-
acyl-L-arginine diamino acid surfactants 
 Compound CMC (mM) γcmc (mN/m) 
Cationic LAGOM 6.5 37.6 
LAPOM 1.5 34.6 
LALM 25* nd 
LAKM 26* nd 
LKKM 22* nd 
Amphoteric LAGOH 1.5 30.0 
LAPOH 0.25 30.0 
Mixtures C8AC 2.1 35 
C10AC 0.49 33 
C12AC 0.19 32 
C14AC 0.071 28 
C16AC 0.034 29 
 




Table 7. Antimicrobial activity based on the MIC values (μg/mL) of cationic and 
amphoteric N-acyl-arginine-amino acid surfactants 
       
 LAGOM LAGuOM LAPOM LALM LAKM LKKM LAGOH LAGuOH LAPOH LALOH 
 Cationic Cationic Amphoteric 
B.subtilis 16 > 16 28 218 115 16 > 4 128 
S. epidermis 16 > 4 218 436 115 16 > 4 > 
M. luteus 32 64 8 28 436 115 16 > 2 128 
           
C. albicans 32 128 16 218 436 R 32 > 4 > 
P.aeruginosa 128 > 
256 
218 R 459 > > 
> 
> 
K. pneumoniae > > 256 218 R 459 > > > > 







Table 8. CMC values obtained by different techniques for compounds XXR and XXRAc. 
 













1010R 0.006b 1.1a  
1212R 0.008a 0.3a 0.3a 
1414R  0.25a  
1212RAc  0.12b  
1414RAc 0.002-0.008b 0.09b  





Table 9. MIC values (mg/L) corresponding to arginine diacyl-glycerolipid conjugates and 
the lysine bisglycidol derivative. 
 
  MICROORGANISMS 88R 1010R 1212R 1414R 1212RAc 1414RAc LGGdi12 
B.  cereus var.mycoides   64 16 >256 >256 4 >256 128 
S. epidermis 8 >256 >256 16 >256 8 128 
M.  luteus     16 1 4 1 2 4 128 
S.  aureus    4 16 >256 256 32 32 64 
B. subtilis     64 2 >256 >256 32 >256 32 
Arthrobacter oxidans  32 16 >256 >256 - -  
S. faecalis  8 4 2 0.5 - -  
S. Typhimurium   16 32 >256 >256 32 >256 256 
P. aeuriginosa     64 >256 >256 >256 >256 >256 256 
E. coli       8 64 >256 >256 >256 >256 128 
B. bronchiseptica     0.25 0.25 0.25 0.25 >256 >256 32 
C. freundii  32 >256 >256 256 >256 >256  
A. faecalis  8 4 >256 256 16 2 - 
 Enterobacter aerogenes     32 >256 >256 16 32 32 >256 
K. pneumonie v. preumonial  8 16 >256 4 8 1 128 

















(C10)2-KKKK-NH2 1.76 43.8 
(C12)2-KKKK-NH2 0.66 45.1 






Table 11. Adsorption properties of bisArgs Cn(XA)2 as a function of the spacer chain 
length in water at 25 ºC. Values in brackets correspond to conductivity data from Pinazo 
et al.69 The cmc of the monocatenary LAM has been also included. 
 








C2(LA)2 9.5 30 C2(CA)2 58 33 
C3(LA)2 4.4 (500) 35 C3(CA)2 43 32 
C4(LA)2 2.8 30 C4(CA)2 48 33 
C6(LA)2 1.3 (400) 30 C6(CA)2 21 33 
C9(LA)2 2.8 (300) 34 C9(CA)2 16 35 
C10(LA)2 1.9 34 C10(CA)2 7.3 36 






























B.subtilis 32 64 64 64 128 32 
S. epidermis 64 8 128 64 128 128 
M. luteus 32 32 8 8 32 16 
S. aureus 32 8 64 64 64 16 
C. albicans 8 16 32 16 32 32 
P.aeruginosa 64 64 64 64 128 >128 
K. pneumoniae 32 16 16 16 32 128 


















B.subtilis 4 64 256 
S. epidermis >128 8 32 
M. luteus 8 32 - 
S. aureus 64 8 256 
C. albicans 16 16 128 
P.aeruginosa >128 64 256 
K. 
pneumoniae 
8 16 256 







Table 14. Influence of the type of cationic charge (trimethylated, guanidine group, α-
amine group and ε-amino group of the lysine) on antimicrobial activity. 
 

















B.subtilis 8 250 250 125 15 
S. epidermis R 63 31 125 15 
M. luteus 16 125 R 125 60 
S. aureus 8 125 R R 60 
C. albicans 16 R R 250 60 




R R R R 






Table 15. Reduction of pathogenic microorganisms (in %) for solutions of MKM, pre-
treated CV and functionalised CV (CV-MKM-HA) 
 % Reduction 
Sample S. aureus E. coli S. agalactiae C. albicans Candida. 
glabrata 
MKM 62 43 59 83 66 
CV 20 18 72 20 58 



























Figure 1. Different routes for the preparation of single chain amino acid surfactants  
Figure 2. Chemical structure of single chain arginine-based surfactants. 
Figure 3. Chemical structure of single chain lysine-based surfactants. 
Figure 4. Chemical structure of modified single chain lysine-based surfactants. 
Figure 5.Transmission electron micrography of (a) S. aureus control cells and (b) S. 
aureus treated with LLM at MIC for 30 min at 25ºC (c) E. coli cells treated with LLM at 
MIC for 30 min at 25ºC and (d) E.coli control. 
Figure 6. Structure of single chain tryptophan and tyrosine surfactants. 
Figure 7. Cationic single chain surfactants from phenylalanine and tyrosine 
Figure 8. Chemical structure of monocatenary surfactants with two amino acids on the 
polar head. 
Figure 9. Nα-acyl-lysine surfactants with a varying number of lysine residues on the 
polar head. 
Figure 10. Nα-acyl-ornithine surfactants with a varying number of lysine residues on 
the polar head. 
Figure 11. Chemical structure of antimicrobial dipeptide-based amphiphiles 
Figure 12. a) Structure of a phospholipid, b) Structure of XXR compounds, 88R n=5, 
1010R n = 7, 1212R n = 9, 1414R n=11, c) Structure of XXRAc compounds, 1212RAc 
n = 9, 1414RAc n = 11. 
Figure 13. Schematic structure of Nε,Nε´-bis(η-acyloxypropyl)-L-lysine methyl ester 
salts. 
Figure 14. Structure of L-lysine surfactants, (Cx)2-KKKK-NH2 (R = C8, C10, C12, 
C14 and C16). 
Figure 15. Chemical structure of single chain and double chain histidine-based 
surfactants. 
Figure 16. Chemical structure of Nα,Nα´-bis(N-dodecyl N,N-dimethylglycine) cystine 
dimethyl ester dihydrochloride, DABC 
Figure 17. General formula for Cn(XA)2 compounds. 
Figure 18. Chemical structure of gemini lysine-based surfactants 
Figure 19. Chemical structure of asymmetric cationic gemini surfactants from lysine 
Figure 20. Dual staining of Staphylococcus aureus ATCC  (a, control culture; b, treated 
population) and Escherichia coli (c, control culture; d, treated population) stained with 
57 
 
propidium iodure and SYTO-13 after exposure to C3(CA)2 at 2/3 MIC concentration 
for 30 min (ref.93). 
Figure 21. Effect of the lysine-based surfactant C6(LL)2 on Staphylococcus aureus 
ATCC 25178 (a, control culture; b, treated population) and Escherichia coli ATCC 
27325 (c, control culture, d, treated population). Time of contact 30 min. at MIC. 
Figure 22. Scanning electron micrographs of wool fabric. Untreated sample and treated 























 Figure 2 
Nα-acyl arginine alkyl ester hydrochloride 
R=CH3 and n=8 CAM, n=10 LAM, n=12 MAM n=14 PAM 
R=CH2-CH3 and n=10 LAE 
Arginine N-alkyl amide dihydrochloride 
n=9 ACA, n=11 ALA, n=13 AMA 
Series 3 
Arginine O-alkyl ester dihydrochloride 
n=7 AOE, n=9 ACE, n=11 ALE 
Sodium salt of Nα-acyl arginine hydrochloride 
n=6 OAS, n=8 CAS, n=10 LAS 
1 acyl-rac-glycero-3-O-(L-arginine) dihydrochloride 










R=lateral alkyl chain of glycine, 
     Valine, Proline, Phenylalanine, 
     Tryptophan, Lysine, and arginine 
Series 11 
Lysine lauroyl amide 
 
Series 7 
a) X=CH3   Nα-Lauroyl-lysine methyl ester (LLM) 
b) x=CH2-CH3 Nα-Lauroyl-lysine methyl ester(LLE) 
c) X=Na  Sodium salt of Nα-Lauroyl-lysine(LLS) 
Series 8 
a) X=CH3   Nα-Lauroyl-Nε-trimethyl-lysine  
                    methyl ester (LLM)q 
b) x=CH2-CH3 Nα-Lauroyl-Nε-trimethyl-lysine                                   
ethyl ester (LLM)q 
Series 6 
Nε-acyl-lysine methyl ester 
n=10 LKM; n=12 MKM; n=14 PKM 
Series 9 
Nα-Miristoyl-Ne-trimethyl-lysine 















Lauroyl amide of lysine dihydrochloride 
13 
Guanidinylated lauroyl amide of lysine 
dihydrochloride 
14 
Polyol modified carbohydrate-template 

































Tyrosine based surfactants Series 15 
Tryptophan based surfactants 
n=9,11,13,15,17 
For n=15 X=Clhoride, hexanoate, phenyl acetate 















R=H, Phenylalanine derivatives (n=0, 1, 2, 3, 7, 9, 11, 13, 15, 17, 19) 









R’=CH3, cationic surfactants 
LAGOM (R=H, glycine), LAPOM R=CH2-C6H5, phenylalanine 
LALM (R=(CH2)4-NH3, Lysine 
 
R’=OH, amphoteric surfactants 
LAGOH (R=H, glycine), LAPOH (R=CH2-C6H5, phenylalanine 
LALOH (R= (CH2)4-NH3 Lysine) LAGuOM (R=(CH2)2-COOH 
 Glutamic acid) 
Series 21 
C8AC-C16AC 
R=residue of amino acid coming from collagen 























x=1, 2, 3, 4, 5 
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